Rapid Micro Biosystems (RPID) Gross Profit (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Gross Profit data on file, last reported at $371000.0 in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 8.17% year-over-year to $371000.0; the trailing twelve-month figure through Mar 2026 stood at $28.9 million (up 1092.23% YoY), and the FY2025 full-year result was $27.0 million, up 285.53% from the prior year.
• Gross Profit declined to $371000.0 in Q1 2026, from $20.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $20.6 million in Q4 2025 to a low of -$8.6 million in Q4 2022.
• A 5-year average of $1.8 million and a median of $1.7 million in 2024 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 711.11% in 2024, while the deepest fall reached 545.91% in 2024.
• Tracing RPID's Gross Profit over 5 years: stood at -$8.6 million in 2022, then surged by 118.99% to $1.6 million in 2023, then slumped by 545.91% to -$7.3 million in 2024, then surged by 382.42% to $20.6 million in 2025, then slumped by 98.2% to $371000.0 in 2026.
• Business Quant data shows RPID's Gross Profit at $371000.0 in Q1 2026, $20.6 million in Q4 2025, and $2.3 million in Q3 2025.